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In  addition  to  its  characteristics  as  a  DNA  binding  transcription  factor, 
HMGA1a is known to bind RNA, sequence specifically and regulate aberrant 
splicing of the Presenilin-2 gene in sporadic Alzheimer’s disease1,2. We show 
here  that  an  RNA  cis-element,  immediately  upstream the  HMGA1a binding 
site, induces exon inclusion upon mutating a GU sequence to CA. Psoralen 
mediated UV crosslinking showed U1 snRNP did not bind this sequence but 
oligonucleotide-mediated  RNase  H  digestion  showed  it  important  for  U1 
snRNP to recognize the authentic 5’ splice site. This sequence (5’-AAGUAC-3’) 
was  tested  for  hnRNPA1  binding  and  function.  Coimmunoprecipitation  of 
endogenous  HMGA1a  and  hnRNPA1  in  HeLa  nuclear  extract,  implicated 
hnRNPA1  to  be  involved  in  HMGA1a  mediated  dysfunction  of  U1  snRNP. 


































was mutated to CA. hnRNPA1 alone had no effect of splicing of a 5’ splice site 
adjacently downstream the HMGA1a binding site, but significantly attenuated 
HMGA1a mediated splicing suppression of this 5’ splice site. Thus, hnRNPA1, 
known as the human homolog of hrp48 in the PSI model, attenuates HMGA1a 
mediated U1 snRNP dysfunction.
Alternative splicing is a critical step for higher eukaryotes to create a vast proteome 
from a limited amount of genes. Recent advances in this field have been focused an 
auxiliary  sequences and proteins nearby the splice sites3,4.  Nearby 5’  splice sites 
which do not function, namely pseudo 5’ splice sites, seem to affect the function of the 
authentic 5’ splice site by simultaneous binding of U1 snRNP and hnRNPA1 to the 
same silencer motif5. Recently, the polypyrimidine tract-binding protein PTB has been 
shown to exert its function in alternative splicing depending on a positional effect of a 
splice site and PTB binding site6.
During a search for the trans-acting factor responsible for aberrant exon exclusion 
of  Presenilin-2 (PS2)  exon 5 found in  sporadic  Alzheimer’s  disease (PS2V 
literature),  HMGA1a was  identified  to  bind  a  motif  (5’-GCUGCUACAAG-3’)  found 
adjacently  upstream  the  5’  splice  site  of  PS2 exon  51.  HMGA1a  induced  exon 
exclusion in vitro and in vivo through this HMGA1a binding RNA motif. A 2’-O-methyl 
RNA oligonucleotide of the HMGA1a binding site would act as a decoy and inhibit 
exon exclusion2. HMGA1a interacted with U1-70K, and expression of U1-70K but not 
U1A,  could  titrate  HMGA1a  induced  exon  exclusion.  U1-70K  and  U1A  are 
components of U1 snRNP, the complex which is commited to the 5’ splice site at the 
earliest  steps  of  spliceosome  assembly.  The  mechanism  was  postulated  that 
HMGA1a recruited U1 snRNP (through binding with U1-70K) to an upstream pseudo 
5’ splice site and leading to dysfunction of the authentic 5’ splice site. In this way, the 
intron downstream the exon with the HMGA1a binding site would show suppressed 
splicing by HMGA1a, which was indeed the case2.
We show here that an upstream pseudo 5’ splice site showed no recruitment of U1 
snRNP by HMGA1a but  the  authentic  5’  splice  site  was influenced by HMGA1a 
binding. An RNA  cis-element upstream the HMGA1a binding site is necessary for 


































binding to this cis-element. The mechanism by which HMGA1a disrupts authentic 5’ 


































 Fig.1 A cis-element upstream the HMGA1a binding site alters exon exclusion. In vitro splicing of 
C14-E5-C15  pre-mRNA  (left  panel)  and  G1-BS1-G2  pre-mRNA  (right  panel).  The  mutation  is 
indicated in red. Mut showed more exon inclusion and less exon exclusion compared to wild type. 
HMGA1a binding site is underlined. Notice the decrease of splicing intermediate only found in exon 
exclusion. * indicates a non-specific band. 
In order to test whether an upstream pseudo 5’ splice site would influence HMGA1a 
mediated exon exclusion, two pre-mRNA substrates (C14-E5-C15 and G1-BS1-G2 2) 
with a mutation of GU to CA was introduced to an upstream GU site. The MAXENT 
scores (http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html)7 are 1.75 
(upstream pseudo 5’ splice site) and 9.16 (authentic 5’ splice site) for the middle exon 
of C14-E5-C15 pre-mRNA and -7.12 (upstream GU site) and 8.46 (authentic 5’ splice 
site) for the middle exon of G1-BS1-G2 pre-mRNA. The GU sequence in G1-BS1-G2 
pre-mRNA was created to resemble the putative hnRNPA1 binding UAG in the UAG 
motif8. As shown in figure 1, mutation of the pseudo 5’ splice site in C14-E5-C15 pre-
mRNA induced exon inclusion (Fig. 1 compare lane 2 to lane 1) in an in vitro splicing 
assay. This was in line with the presumption that an upstream pseudo 5’ splice site 
would function in  HMGA1a mediated exon exclusion.  We tested G1-BS1-G2 pre-


































the  mutation  in  this  pre-mRNA  would  not  influence  exon  exclusion.  But,  on  the 
contrary, this mutation also induced exon inclusion (Fig. 1 compare lane 4 to lane 3). 
Thus, both a pseudo 5’ splice site and upstream GU site seemed to be involved in 
HMGA1a mediated exon exclusion.
Fig.2  Psoralen  mediated 
UV  crosslinking  of  U1 
snRNP  to  PS2E5  RNA. 
The  native  upstream 
sequence (shown in upper 
part (HMGA1a binding site 
is underlined.) (Mutation is 
in red.)) of Presenilin-2 was 
used  to  psoralen  UV 
crosslink  U1  snRNP  of 
HeLa nuclear extract.
We could not determine whether a pseudo 5’ splice site or hnRNPA1 binding site 
was involved in HMGA1a mediated exon exclusion by in vitro splicing. So, we checked 
U1 snRNP binding to the 5’ splice sites by psoralen mediated UV crosslinking. We 
used the native sequence upstream the 5’ splice site of PS2 exon 5. As shown in 
figure 2, two bands were found crosslinked when we used the wild type PS2E5 RNA 
(PS2E5 wt) (Fig. 2 lane 2), the band migrating faster was also found in the mutant 


































oligonucelotide / RNase H digestion (Fig. 2 lane 8) but not by anti-U2 (Fig. 2 lane 7) 
implicating that  this  was U1 snRNA annealed and crosslinked to the authentic  5’ 
splice site. However, the bands of wild type RNA were resistant to anti-U1 (Fig. 2 lane 
7). Even if U1 snRNP was recruited to the upstream pseudo 5’ splice site, it should be 
digested by anti-U1 since digestion was performed prior to psoralen mediated UV 
crosslinking.  It  may be U1 snRNP annealed and crosslinked to the 5’  splice site 
through other parts of U1 snRNA. A candidate would be (5’-agataccat-3’), which starts 
from the 19th nucleotide of U1 snRNA. The antisense has a weak 5’ splice site score 
of 3.16 (MAXENT)7, which is in the stem of U1 snRNA and unlikely to unfold. Analysis 
of this is beyond the aim of this study, and lack of thorough RNase H digestion may be 
the answer.
Fig.3  Psoralen  mediated  UV 
crosslinking  of  U1  snRNP  in 
combination  with  RNase  H 
sensitivity assay. After psoralen 
UV  crosslinking,  antisense  DNA 
oligonucleotide   and   
indicated in the upper part  were 
used  for  RNase  H  digestion. 
2’-O-methyl RNA of the HMGA1a 
binding  site  (HMGA1a  BS)  was 
used  to  titrate  endogenous 
HMGA1a in HeLa nuclear extract.
When  we  combined  a  RNase  H  sensitivity  assay  with  psoralen  mediated  UV 
crosslinking (Fig. 3), there was no difference of U1 snRNA/authentic 5’ splice site 
crosslinking in PS2E5 wt and PS2E5 mut (Fig. 3 lanes 2 and 14). If U1 snRNP was 
recruited to the upstream pseudo 5’  splice site,  a difference should be observed 


































also observed in both the PS2E5 wt and PS2E5 mut, thus these two bands seem to 
be U1 snRNP annealed and crosslinked to the authentic 5’ splicing site. One of these 
bands may be an internal crosslink of U1 snRNA itself, which is already known9.10. But 
this is unlikely because these reactions were done in splicing conditions where U1 
internal crosslinks tend not to appear10. Resistance to anti U1 digestion in figure 2 lane 
4 could not be observed in figure 3 lane 4. In figure 3, antisense  and  
DNA oligonucleotide / RNase H digestion was performed which means RNase H was 
added twice in  anti  U1 and U2 digestion samples,  which may have ensured the 
RNase H digestion leading to anti U1 digestion in figure 3 but not figure 2. The most 
logical interpretation for the slow migrating band of U1 snRNA/authentic 5’ splice site 
crosslinking in PS2E5 wt may be that an unusual form of U1 snRNP was induced by 
the upstream GU binding protein in these limited conditions. In figure 2, U1 snRNP 
may have crosslinked to internal crosslinks of PS2E5 which can be recognized as a 
slightly slower migrating band in figure 2 lanes 2,3,4 and 6,7,8. But since, internal 
crosslink of PS2E5 can be observed in both wt and mut, this can not explain the 
differential U1 snRNP crosslinking to PS2E5 wt and mut. And in figure 3, which has 
additional RNase H cleavage do not show internal crosslinks of PS2E5 and still two 
U1 snRNP related bands can be observed in PS2E5 wt. At least, what can be said 
from this data is that the upstream GU is important for this slower migrating band, and 
seems to be unrelated to HMGA1a since it can not be observed in HMGA1a BS lanes 
(Fig. 3 lanes 12 and 24).
When 2’-O-methyl RNA of the wild type HMGA1a binding site (HMGA1a BS) was 
added,  wild  type  PS2E5  showed  a  band  resistant  to  cleavage  by  antisense 
oligonucleotide  / RNase H (Fig. 3 lane 6, band with slightly slower mobility than 
cleaved exon, corresponding to exon with intron ). HMGA1a BS is known to prevent 
exon exclusion and induce exon inclusion, as shown in previous studies2. Thus, this 
resistant band may mean proper U1 snRNP binding to the authentic 5’ splice site was 
induced in HMGBS, while it was not in PS2E5 mut (Fig. 3 lane 18). The upstream GU 
to CA mutation did not induce U1 snRNP occupancy, which is a resistant band to anti 
 digestion, found in figure 3 lane 6 (faint top band) but not found in figure 3 
lanes 14,15,17 and not even 18. So, exon inclusion induced by the GU to CA mutation 
seems to be related to HMGA1a induced exon exclusion. This is also evidenced by 
anti  digestion. When HMGA1a BS was added to PS2E5 wt, an increase of U1 
snRNP/authentic 5’ splice site crosslink was detected, with resistance to anti   
digestion (Fig. 3 lane 12). This was not found in the PS2E5 mut (Fig. 3 lane 24). The 
upstream cleavage site may not be cleaved by anti  digestion because the site 
is mutated, but the downstream cleavage site should be cleaved as in the wild type. 


































anti   digestion (Fig. 3 compare lanes 14,15 to 2,3) but more crosslink in anti 
 digestion (Fig. 3 compare lanes 20,21 to 8,9). U1 snRNP seems to anneal to 
more nucleotides upstream the authentic 5’  splice site, and becomes unrelated to 
HMGA1a mediated U1 snRNP dysfunction when the upstream GU is mutated to CA. 
In summary, the upstream GU is  involved in U1 snRNP/authentic 5’  splice site 
dysfunction  through  HMGA1a  mediated  mechanism,  but  how  HMGA1a  disturbs 
authentic 5’ splice site function can not be explained.
Fig.4  hnRNPA1  interacts  with  HMGA1a  and  attenuates  HMGA1a  mediated  splicing 
suppression.   a,  Endogenous HMGA1a was immunoprecipitated by anti-HMGA1a antibody and 
revealed by anti-hnRNPA1 antibody (left panel, white arrow is hnRNPA1). b, RNA EMSA of hnRNPA1 
using PS2E5 wt and mut as probe. Black arrowhead is hnRNPA1 binding to RNA. c, hnRNPA1 did 
not  affect  splicing  of  BS1-E6 pre-mRNA in  an  in  vitro splicing  assay,  but  when combined  with 
HMGA1a, splicing suppression was attenuated (right panel). (HMGA1a binding site is depicted as 
black box in right side) 


































whether hnRNPA1 is involved. First, interaction between hnRNPA1 and HMGA1a was 
checked. We were able to immunoprecipitate endogenous hnRNPA1 protein with anti-
HMGA1a antibody (Fig. 4a). hnRNPA1 had a slightly better affinity to PS2E5 wt than 
mut RNA in an RNA electrophoretic mobility shift assay (Fig. 4b, compare lanes 5,6 to 
9,10). This sequence (5’-AAGUAC-3’) has low homology to exon splicing silencer 3 of 
HIV-Tat exon 3  (5’-UAGUGA-3’)  where hnRNPA1 binds and functions11.  And also 
different from the putative hnRNPA1 binding UAG motif8,(5’-UAGGG-3’). The core of 
the  sequence  (5’-AGUA-3’)  is  part  of  UAG in  tandem (5’-UAGUAG-3’)  (common 
sequence in bold). 
hnRNPA1 alone did not affect splicing of BS1-E6 pre-mRNA (Fig. 4 compare lanes 
13 and 14 to lane 12), but attenuated the splicing suppression by HMGA1a (Fig. 4 
compare lanes 17 and 18 to lane 16). Thus, hnRNPA1 has low affinity to the upstream 
GU sequence, but functions in concert with HMGA1a.
Fig.5  Comparison  of  the 
PSI  model  and  the 
HMGA1a  model.  HMGA1a 
mediated exon exclusion is 
reminiscent  of  the  PSI 
model except that hnRNPA1 
functions  as  a  synergistic 
trans-cofactor of HMGA1a.
From the results above, hnRNPA1 and HMGA1a possibly interact, and hnRNPA1 
attenuates  HMGA1a mediated  splicing  suppression.  This  is  quite  reminiscent  but 
different from the PSI model in Drosophila12-22 (Fig. 5) in two aspects. First, the human 
homolog of hrp48 is known to be hnRNPA121, but while hrp48 plays an essential role 
in splicing of P-element third intron (IVS3), hnRNPA1 alone does not affect splicing of 
pre-mRNA containing an HMGA1a binding site adjacently upstream the 5’ splice site. 
Second, while U1 snRNP is recruited to an upstream pseudo 5’ splice site in IVS3 
splicing,  U1  snRNP is  binding  the  authentic  5’  splice  site  in  HMGA1a mediated 
splicing  suppression.  The  mechanism  for  HMGA1a  mediated  dysfunction  of  the 
authentic 5’ splice site has to be elucidated, but at least what we can say here is that 
hnRNPA1 is an important factor to stabilize HMGA1a mediated splicing suppression. 
HMGA1a is not an essential splicing factor, as it is barely expressed in normal cells. It 


































stimulus such as hypoxia 1,25,26, chronic aluminum exposure27 in sporadic Alzheimer’s 
patients brain and neural cells. From its potential as an oncogenic product28, HMGA1a 
induced aberrant splicing of Estrogen receptor alpha was checked in MCF-7 breast 
cancer cells, and indeed an aberrant 46 kDa isoform was found to be induced by 
HMGA1a RNA binding  (data  not  shown).  It  would  be  interested  to  check  global 
aberrant splicing induced by HMGA1a in cancer cells. Recently, the essential splicing 
factor Fox2 has been analyzed in cancer related splicing29. It would also be interesting 
to check the relationship of Fox2 induced and HMGA1a induced alternative splicing in 
cancerous cells30.
How HMGA1a abrogates the adjacently downstream authentic 5’ splice site can not 
be explained from our data. From the RNase H sensitivity assay, it seems HMGA1a 
changes the pattern of U1 snRNA annealing to the authentic 5’ splice site. When we 
did a time course of U1 snRNA/5’ splice site annealing, HMGA1a decreased normal 
dissociation of U1 snRNP from the 5’ splice site, which is necessary for U5 and U6 
snRNP to anneal near the 5’ splice site in later steps of spliceosome assembly (data 
not shown). How U1 snRNA unwinding is disrupted by HMGA1a awaits structural and 
further biochemical studies.
Methods
Antibodies, plasmids and Oligonucleotides.  Anti HMGA1a antibody (FL95) was 
purchased from Santa Cruz. Anti hnRNPA1 antibody (9H10) was a kindly provided by 
G. Dreyfuss. To construct  δ-crystallin based heterologous plasmid (for C14-E5-C15 
pre-mRNA), exon 5 and flanking intron sequences (221 bp for 5’ and 51 bp for 3’ 
intron  sequences)  of  the  Presenilin-2 (PS2)  exons  4–6  mini-gene  plasmid1 was 
amplified by PCR with flanking ApaI and NcoI sites, and the amplified fragment was 
subcloned into a PCR product  which amplified pSP14-1530 digested with  SacI  by 
oligonucleotides with flanking ApaI and NcoI restriction sites (51 bp downstream from 
the  3’  end  of  exon 14).  The resulting  C14-E5-C15 pre-mRNA includes,  77  bp  of 
pSP14-15 first exon - 68 bp of pSP14-15 intron sequence – ApaI site – 221 bp of PS2 
intron sequence – PS2 exon 5 – 51 bp of PS2 intron sequence – NcoI site – 185 bp of 
pSP14-15 intron sequence – 63 bp of pSP14-15 second exon. The plasmid for G1-
BS1-G2 is previously described 2. 2’-O-methyl RNA of HMG binding site (wt and mut) 
were purchased from FASMAC (Kanagawa, Japan).  For RNase H sensitivity assay, 


































(5’-GGTACTTGTAG-3’) were used, purchased from  Texas Genomics Japan (Tokyo, 
Japan).
In vitro splicing assay. Plasmids were linearized by restriction enzymes (SmaI for 
C14-E5-C15,  BamHI  for G1-BS1-G2, and XbaI  for BS1-E6 plasmids) and used as 
template DNAs for  in vitro transcription.  Preparation of GpppG-capped  32P-labeled 
pre-mRNA  substrates  by  in  vitro transcription  with  SP6  RNA  polymerase  was 
performed as described32. For C14-E5-C15, the full-length transcript was purified by 
preparative electrophoresis on a 5.5% polyacrylamide/7 M urea gel for the  in vitro 
splicing assays as described 32.
Psoralen mediated UV crosslinking.  A mixture of  in  vitro  splicing was used to 
conduct psoralen mediated UV crosslinking according to the reported method with 
slight modifications10,22. Each reaction mixture (in a final volume of 12.5 l )  containing 
~20  fmol  of  32P-labeled  pre-mRNAs  and  200  ng  of  a  psoralen  derivative 
(4’-aminomethyl-trioxsalen hydroxy-chloride; Calbiochem) was incubated at 37°C for 
15 minutes in the presence of 3 mM ATP, 20 mM creatine phosphate, 20 mM HEPES 
(pH 7.3), 3.5 mM MgCl2, 2% (w/v) of low-molecular-weight polyvinyl alcohol (Sigma), 
and 3.5 l  of HeLa cell nuclear extract (CilBiotech). The mixture was irradiated with 
UV light (365 nm) for 15 min on ice at a distance of 3 cm from the light source (CSL-
6A,  Cosmo Bio).  RNA was  extracted  with  phenol,  precipitated  with  ethanol,  and 
fractionated on a denaturing 7% polyacrylamide gel. Dried gels were visualized using 
a Bio-imaging Analyzer (Fujix BAS1000; Fujifilm). To identify crosslinked products of 
RNA or pre-mRNA that interacted with U1 snRNA or RNase H sensitivity assay, we 
performed antisense oligonucleotide-directed  RNase H digestion.  Oligonucleotides 
(15 nt) complementary to the 5’ ends of the U1 or U2 snRNAs were used as described 
previously33. To digest endogenous U1snRNA prior to psoralen UV crosslinking, 3.5 
l  of  HeLa cell  nuclear  extract  was incubated at  37°C  for 20 min in a 12.5 l  
reaction mixture containing 50 pmol of each antisense oligonucleotide, 2 U RNase H 
(Takara Bio), and 3 mM MgCl2. 
RNA electrophoretic mobility shift assay.  Each reaction mixture (in total 15 l )  
was incubated at 37°C for 20 min in a binding buffer containing 3 mM MgCl2, 50 mM 
KCl, 20 mM Tris-HCl (pH 7.5), 0.05 mM EDTA, 0.1% (v/v) Triton X-100, 10% (v/v) 


































complexes were analyzed by electrophoresis on a 5% nondenaturing polyacrylamide 
gel [acrylamide:bisacrylamide = 30:1 (w/w)] at 4°C with 0.5 xTris-borate-EDTA (TBE) 
buffer. Dried gels were visualized by a Bio-imaging Analyzer (Fujix BAS1000; Fujifilm).
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